AXNX

Axonics Modulation Technologies Inc.

Price

return (12m)

p/e

-639.57

p/bv

5.45

DIVIDEND YIELD

0.00%

AXNX price

Axonics Modulation Technologies

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AXNX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AXNX

Valuation

P/E

-639.57

Sector 1.09

Industry -1.78

P/BV

5.45

Sector 1.86

Industry 1.35

P/Revenue (PSR)

8.38

Sector 1.55

Industry 2.25

EV/EBITDA

7,797.02

Sector -47.62

Industry -42.38

EV/EBIT

-1,173.75

Sector -27.52

Industry -45.58

P/EBITDA

479.47

Sector -32.64

Industry -23.10

P/EBIT

-902.74

Sector -43.02

Industry -27.18

P/Total Assets

4.68

Sector 0.87

Industry 0.82

P/Net Current Assets

8.70

Sector -27.09

Industry -72.46

P/Working Capital

7.84

Sector -4.05

Industry -2.10

EPS

-0.11

Sector -0.70

Industry -1.11

BVPS

13.03

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

76.59%

Sector 49.36%

Industry 50.48%

EBITDA Margin

0.36%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-2.40%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

-1.67%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-1.31%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.15

Sector 0.13

Industry 0.06

Profitability

ROE

-0.85%

Sector -24.32%

Industry -33.33%

ROA

-0.73%

Sector -24.41%

Industry -45.72%

ROIC

-0.04%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

8.16

Sector 1.90

Industry 2.51

Net Debt / EBITDA

-821.98

Sector -4.96

Industry -8.98

Net Debt / EBIT

123.74

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.52

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.86

Sector 0.46

Industry 0.52

Liabilities/Assets

0.86

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

19.09%

Sector -

Industry -

5Y Earnings CAGR

-41.13%

Sector -

Industry -

Fundamentals AXNX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AXNX Axonics Modulation Technologies Inc.	$0.00	-	0.00%	-639.57	5.45	-0.85%	-1.31%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.65	-8.23%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.32	-4.12%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$88.64	15.96%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$180.03	-1.10%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$88.26	17.37%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.59	14.02%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$27.54	-23.70%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$82.52	17.96%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AXNX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Axonics Modulation Technologies

Axonics Modulation Technologies Inc.

Average Investor10 user rating

4.0 (1 people)

United States

14 years

Founded: 2012

2018

Time since IPO - 8 years

416

Employees

Axonics Modulation Technologies Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.62 billion, with shareholders equity totaling $664.49 million.

The company employs approximately 416 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Axonics Modulation Technologies Inc. reported $431.89 million in revenue, generating net income of $-5.66 million.

Key financial metrics include a P/E ratio of -639.57, a price-to-book (P/B) ratio of 5.45, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AXNX.

Market cap

$3.62 billion

Net worth

$664.49 million

$664,490,000.00

Assets

$774.17 million

$774,170,000.00

Total Shares Outstanding

51.00 million

51,000,000

Average Daily Trading Volume

$503.47 Thousand

$503,470.88

Sector

Health

Industry

Medical Supplies and Equipment

AXNX

AXNX revenue and profits

Financial Results AXNX

DRAG THE FRAME TO SEE MORE DATA

AXNX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35